Takeda Chemical Industries and Beth Israel Deaconess announce research agreement

OSAKA, JAPAN & BOSTON, MA. Takeda Chemical Industries, LTD, and Beth Israel Deaconess Medical Center (BIDMC) announced today they have signed a research agreement to investigate the molecular basis of diabetes and obesity and to develop new therapies for these metabolic diseases, which are among the fastest growing and most serious health problems today.

The three-year agreement, which totals $13.7 million, calls for collaboration between Takeda and a team of world-renowned scientists led by BIDMC Chief Academic Officer Jeffrey S. Flier, M.D. Principal investigators include BIDMC Chief of Endocrinology Barbara Kahn, M.D., Bradford Lowell, M.D., Ph.D., Joel Elmquist, D.V.M., Ph.D., Anthony Hollenberg, M.D. , and BIDMC Chief of the Division of Signal Transduction Lewis Cantley, Ph.D.

Independently, each of the members of the BIDMC team is a leader in the fields of endocrinology and metabolic disease, having extensively investigated the molecular basis of leptin resistance in obesity, the cellular and molecular mechanisms for insulin resistance in diabetes, and the role of the brain to hunger and satiety. Over the past year alone, these investigators have published more than 45 papers in the world's leading scientific journals, including Science, Nature, Cell, and The New England Journal of Medicine.

Takeda Chemical Industries, an industry leader in the development of diabetes therapies, is Japan's largest pharmaceutical firm and one of the 15 largest pharmaceutical companies worldwide. More than 1,000 researchers at Takeda carry out world-class research using advanced technology in such fields as human genetics, receptors, and enzymes.

"We are extremely pleased and honored to enter into this collaboration with Beth Israel Deaconess Medical Center," said Takashi Soda, Ph.D., General Manager of Takeda's Pharmaceutical Research Division. "In choosing this partnership, we will be collaborating with one of the most prominent and accomplished groups of

Contact: Bonnie Prescott
Beth Israel Deaconess Medical Center

Page: 1 2 3

Related biology news :

1. Chemical engineering grad students will take notable national awards
2. Chemical derived from vitamin-E shows early promise as cancer drug
3. Chemical genetics identifies SARS inhibitors
4. Chemical signals health of brain cells Symposium
5. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
6. Chemical engineers discover filtration system to help biotech industry
7. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
8. American Chemical Society media registration
9. Chemical Society announces EPA awards for environmentally friendly technology
10. NIH launches first center in Nationwide Chemical Genomics Network
11. Chemical reaction in birds provides sense of direction during migratory flights

Post Your Comments:

(Date:3/2/2020)... ... March 02, 2020 , ... ... 71st annual Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy ( Pittcon 2020 ... Pittcon is the world’s leading annual conference and exposition on laboratory science, attracting ...
(Date:2/28/2020)... ... February 26, 2020 , ... ... its patent-pending Rebound PRP™ and Rebound PRF® devices are now available to ... generation of regenerative medical devices, that will provide the most affordable, easiest ...
(Date:2/28/2020)... ... February 27, 2020 , ... Regen Suppliers is now offering the ... PDO thread lift products are not only one of the only FDA Cleared ... lift procedures are increasing exponentially in popularity, as they represent an excellent nonoperative method ...
Breaking Biology News(10 mins):
(Date:1/28/2020)... ... January 28, 2020 , ... Lifecycle ... to food and beverage manufactures within North America. Both Lifecycle and Midland have ... will allow each company to pool their collective resources and provide the industry ...
(Date:1/28/2020)... ... January 28, 2020 , ... ... Assay Kits . The new Salivary Total Human IgG Assay Kit ... immunoglobulin G in saliva, researchers can extend the accuracy and ease of use ...
(Date:1/27/2020)... ... January 27, 2020 , ... Valencell, the leading innovator ... investors led by Halma plc , a FTSE 100 global group of ... LLC, and WSJ Joshua Fund. A representative from Halma will join the Valencell ...
(Date:1/24/2020)... (PRWEB) , ... January 24, 2020 , ... ... innovations created by companies in biotechnology, diagnostics, therapeutics, laboratory and clinical services during ... millions of people around the world. And as Slone Partners celebrates ...
Breaking Biology Technology:
Cached News: